Detalhe da pesquisa
1.
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer.
Cancer Immunol Immunother
; 62(1): 137-47, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22865266
2.
An analysis of leukapheresis and central venous catheter use in the randomized, placebo controlled, phase 3 IMPACT trial of Sipuleucel-T for metastatic castrate resistant prostate cancer.
J Urol
; 189(2): 521-6, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23253957
3.
Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer.
J Urol
; 186(3): 877-81, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21788048
4.
T-Cell Malignancies With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.
Blood Adv
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38861341
5.
Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials.
Clin Cancer Res
; 23(1): 13-20, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27742793
6.
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
Curr Med Res Opin
; 22(1): 169-83, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16393443
7.
Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage Immunotherapy.
Cancer Immunol Res
; 3(9): 1063-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943532
8.
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome.
Clin Cancer Res
; 21(16): 3619-30, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25649018
9.
Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial.
Urology
; 81(6): 1297-302, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23582482
10.
Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancer.
Urology
; 82(2): 410-5, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23896100
11.
Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.
J Natl Cancer Inst
; 104(14): 1107-9; author reply 1109-12, 2012 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22825556
12.
Etanercept in adult patients with early onset ankylosing spondylitis.
J Rheumatol
; 33(8): 1634-6, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16881118
13.
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
J Rheumatol
; 33(5): 854-61, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16541481
14.
Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.
Arthritis Rheum
; 54(6): 1987-94, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16732547
15.
Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.
J Rheumatol
; 32(7): 1232-42, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15996057
16.
Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability.
J Rheumatol
; 31(8): 1532-7, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15290731
17.
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept.
J Rheumatol
; 31(7): 1356-61, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15229957